Why are NGO s sceptical of genome editing?

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Why are economists sceptical about agent-based simulations?

Despite many years of active research in the field and a number of fruitful applications, agent-based modeling has not yet made it through to the top ranking economic journals. In this paper we investigate why. We look at the following problematic areas: (i) interpretation of the simulation dynamics and generalization of the results, and (ii) estimation of the simulation model. We show that the...

متن کامل

How Hard Are the Sceptical Paradoxes?

The sceptic about the external world presents us with a paradox: an apparently acceptable argument for an apparently unacceptable conclusion—that we do not know anything about the external world. Some paradoxes, for instance the liar and the sorites, are very hard. The defense of a purported solution to either of these two inevitably deploys the latest in high-tech philosophical weaponry. On th...

متن کامل

Why `̀ Sound s Are Judged Longer Than

Three experiments, using temporal generalization and verbal estimation methods, studied judgements of duration of auditory (500-Hz tone) and visual (14-cm blue square) stimuli. With both methods, auditory stimuli were judged longer, and less variable, than visual ones. The verbal estimation experiments used stimuli from 77 to 1183 msec in length, and the slope of the function relating mean esti...

متن کامل

Advancing Chimeric Antigen Receptor-Engineered T-Cell Immunotherapy Using Genome Editing Technologies: Challenges and Future Prospects

Chimeric antigen receptor engineered-T (CAR-T) cells also named as living drugs, have been recently known as a breakthrough technology and were applied as an adoptive immunotherapy against different types of cancer. They also attracted widespread interest because of the success of B-cell malignancy therapy achieved by anti-CD19 CAR-T cells. Current genetic toolbox enabled the synthesis of CARs ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: EMBO reports

سال: 2017

ISSN: 1469-221X,1469-3178

DOI: 10.15252/embr.201744385